Products for Research Use Only
RegisterLogin

Emirodatamab

CAT: 0931-T9901A-098-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T9901A-098-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2449199-61-3
Target
FLT
Related Pathways
Angiogenesis, Tyrosine Kinase/Adaptors
Bioactivity
Emirodatamab (AMG-427) is an anti-FLT3/CD3 bispecific T-cell engager with an extended half-life. It can induce high cytotoxicity in primary AML progenitor cells and enhance FLT-3 expression. Combining Emirodatamab with anti-PD-1 antibodies increases T-cell dependent cytotoxicity (TDCC) . This compound is under investigation for use in relapsed or refractory AML.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
HY-P99916-01Emirodatamab
GTR18575776-01Emirodatamab Antibody
DHE19101Research Grade Emirodatamab
E55B1293Emirodatamab (Reference antibody)
ICH5520-10mgEmirodatamab Biosimilar - Research Grade
GTR18697232-01Emirodatamab Human Monoclonal Antibody
PX-TA1833-01Emirodatamab Biosimilar - Anti-FLT3; CD3E mAb - Research Grade
A135605Emirodatamab Biosimilar (Monoclonal, (scFv-heavy-kappa) - (scFv-heavy-lambda) -scFc)

Popular Products